Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party

被引：0

作者：

Brijs, J. ^{[1
]}

Peczynski, C. ^{[2
,3
]}

Boreland, W. ^{[2
,3
]}

Cuoghi, A. ^{[4
]}

Maertens, J. ^{[1
,5
]}

Mohty, M. ^{[6
]}

Kroeger, N. ^{[7
]}

Nakov, P. ^{[8
]}

Broers, A. E. C. ^{[9
]}

Eder, M. ^{[10
]}

Arroyo, C. Herrera ^{[11
]}

Kaufmann, M. ^{[12
]}

Ram, R. ^{[13
]}

Schaap, N. P. M. ^{[14
]}

Graham, C. ^{[3
,15
]}

Mussetti, A. ^{[3
,16
]}

Penack, O. ^{[3
,17
]}

Moiseev, I. ^{[3
,18
]}

Peric, Z. ^{[3
,19
,20
]}

Schoemans, H. ^{[1
,3
,21
]}

机构：

[1] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium

[2] Sorbonne Univ, EBMT Paris Study Off, St Antoine Hosp, EBMT Paris Study Off,CEREST TC,INSERM UMR-S 938, Paris, France

[3] INRIA, Paris, France

[4] Univ Modena, Azienda Ospedaliero, Modena, Italy

[5] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium

[6] Univ UPMC, Hop St Antoine, INSERM, Paris, France

[7] Univ Med Ctr Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany

[8] Univ Hosp Schleswig, Dept Med 2, Campus Kiel, Holstein Campus Kiel, D-24105 Kiel, Germany

[9] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

[10] Hannover Med Sch, Dept Hematol, Hannover, Germany

[11] Hosp Univ Reina Sofia, Cordoba, Spain

[12] Robert Bosch Hosp Stuttgart, Stuttgart, Germany

[13] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv Sourasky Med Ctr,Bone Marrow Transplantat, IL-69978 Tel Aviv, Israel

[14] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[15] Kings Coll London, Comprehens Canc Ctr, London, England

[16] Inst Invest Biomed Bellvitge IDIBELL, Hosp Duran i Reynals, Catalan Inst Oncol, Dept Hematol, LHospitalet de Llobregat, Barcelona, Spain

[17] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Med Clin, Berlin, Germany

[18] Pavlov First St Petersburg State Med Univ, RM Gorbacheva Res Inst, St Petersburg, Russia

[19] Univ Rijeka, Univ Hosp Ctr Rijeka, Dept Hematol, Rijeka, Croatia

[20] Univ Rijeka, Sch Med, Rijeka, Croatia

[21] KU Leuven Univ Leuven, Dept Publ Hlth Primary Care, ACCENTVV, Leuven, Belgium

来源：

BONE MARROW TRANSPLANTATION | 2024年

关键词：

BLOCKADE;

D O I：

10.1038/s41409-024-02497-8

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：415 / 417

页数：3

共 12 条

[1] CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Bashey, Asad
Medina, Bridget
Corringham, Sue
Pasek, Mildred
Carrier, Ewa
Vrooman, Linda
Lowy, Israel
Solomon, Scott R.
Morris, Lawrence E.
Holland, H. Kent
Mason, James R.
Alyea, Edwin P.
Soiffer, Robert J.
Ball, Edward D.
[J]. BLOOD, 2009, 113 (07) : 1581 - 1588
[2] Blazar BR, 1999, J IMMUNOL, V162, P6368
[3] Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
Cecchini, Michael
Sznol, Mario
Seropian, Stuart
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
[4] B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
Fridman, Wolf H.
Meylan, Maxime
Petitprez, Florent
Sun, Cheng-Ming
Italiano, Antoine
Sautes-Fridman, Catherine
[J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (07) : 441 - 457
[5] PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Haverkos, Bradley M.
Abbott, Diana
Hamadani, Mehdi
Armand, Philippe
Flowers, Mary E.
Merryman, Reid
Kamdar, Manali
Kanate, Abraham Sebastian
Saad, Ayman
Mehta, Amitkumar
Ganguly, Siddhartha
Fenske, Timothy S.
Hari, Parameswaran
Lowsky, Robert
Andritsos, Leslie
Jagasia, Madan
Bashey, Asad
Brown, Stacey
Bachanova, Veronika
Stephens, Deborah
Mineishi, Shin
Nakamura, Ryotaro
Chen, Yi-Bin
Blazar, Bruce R.
Gutman, Jonathan
Devine, Steven M.
[J]. BLOOD, 2017, 130 (02) : 221 - 228
[6] Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation
Ijaz, Awais
Khan, Ali Younas
Malik, Saad Ullah
Faridi, Warda
Fraz, Muhammad Asad
Usman, Muhammad
Tariq, Muhammad Junaid
Durer, Seren
Durer, Ceren
Russ, Atlantis
Parr, Nadia Nunes Cavalcante
Baig, Zeeshan
Sagar, F. N. U.
Ali, Zeeshan
McBride, Ali
Anwer, Faiz
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 94 - 99
[7] Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Martins, Filipe
Sofiya, Latifyan
Sykiotis, Gerasimos P.
Lamine, Faiza
Maillard, Michel
Fraga, Montserrat
Shabafrouz, Keyvan
Ribi, Camillo
Cairoli, Anne
Guex-Crosier, Yan
Kuntzer, Thierry
Michielin, Olivier
Peters, Solange
Coukos, Georges
Spertini, Francois
Thompson, John A.
Obeid, Michel
[J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) : 563 - 580
[8] Immune checkpoints inhibitors for solid tumours after allogeneic haematopoietic stem-cell transplantation: About four clinical cases
Monneur, Audrey
Monnier, Jilliana
Gaudy-Marqueste, Caroline
Devillier, Raynier
Sabatier, Renaud
[J]. EUROPEAN JOURNAL OF CANCER, 2017, 81 : 138 - 141
[9] Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation
Ortega, Sanchez Guacimara
Frank, Stenner
Stefan, Dirnhofer
Jakob, Passweg
Sabine, Gerull
Jorg, Halter P.
Alfred, Zippelius
Heinz, Laubli
[J]. SWISS MEDICAL WEEKLY, 2019, 149
[10] Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease
Schaar, Dana A.
Pirsl, Filip
Holtzman, Noa
Steinberg, Seth M.
Nashed, Jeannette
Ruben, Claire
Cowen, Edward W.
Mays, Jacqueline W.
Mitchell, Sandra
Ostojic, Alen
Munshi, Pashna N.
Joe, Galen O.
Comis, Leora E.
Morton, Lindsay
Pavletic, Steven Z.
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 937.e1 - 937.e7

← 1 2 →